*NURSING > EXAM > Nursing MSN 517 FINAL EXAM Advanced Pharm (WEEK 8-11) PRIME EXAM HIGHLY GUARANTEED PASS 100% 2023 (All)

Nursing MSN 517 FINAL EXAM Advanced Pharm (WEEK 8-11) PRIME EXAM HIGHLY GUARANTEED PASS 100% 2023

Document Content and Description Below

Nursing MSN 517 FINAL EXAM Advanced Pharm (WEEK 8-11) PRIME EXAM HIGHLY GUARANTEED PASS 100% 20231) A 40-year old female patient is being followed up for diabetes mellitus. She is currently on Metform... in 1 gram twice a day and has been tolerating it well for about six months. Her hemoglobin A1c a week ago was 8.9%. The plan is to initiate liraglutide therapy in addition to the metformin. Which of the following statements is true with regards to liraglutide. ▪ Liraglutide may be stored in the refrigerator or freezer prior to first use. ▪ The brand name is Bydureon ▪ Nausea and/or vomiting are common side effects of therapy ▪ It should be administered intramuscularly into the upper arm. 2) The patient who takes insulin has just been prescribed a beta blocker drug. You recognize that the interaction of the beta blocker and the insulin may have which result? ▪ Decreased activity of the beta blocker drug ▪ Enhanced activity of the beta blocker drug ▪ Masked signs of hypoglycemia ▪ Masked signs of hyperglycemia 3) The drug of choice for type 2 diabetics is metformin. Metformin: ▪ Increases intestinal uptake of glucose [Show More]

Last updated: 2 years ago

Preview 1 out of 11 pages

Buy Now

Instant download

We Accept: